the cardio vascular disease power point .docx

drsanjaybedi 86 views 195 slides Jul 06, 2024
Slide 1
Slide 1 of 195
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72
Slide 73
73
Slide 74
74
Slide 75
75
Slide 76
76
Slide 77
77
Slide 78
78
Slide 79
79
Slide 80
80
Slide 81
81
Slide 82
82
Slide 83
83
Slide 84
84
Slide 85
85
Slide 86
86
Slide 87
87
Slide 88
88
Slide 89
89
Slide 90
90
Slide 91
91
Slide 92
92
Slide 93
93
Slide 94
94
Slide 95
95
Slide 96
96
Slide 97
97
Slide 98
98
Slide 99
99
Slide 100
100
Slide 101
101
Slide 102
102
Slide 103
103
Slide 104
104
Slide 105
105
Slide 106
106
Slide 107
107
Slide 108
108
Slide 109
109
Slide 110
110
Slide 111
111
Slide 112
112
Slide 113
113
Slide 114
114
Slide 115
115
Slide 116
116
Slide 117
117
Slide 118
118
Slide 119
119
Slide 120
120
Slide 121
121
Slide 122
122
Slide 123
123
Slide 124
124
Slide 125
125
Slide 126
126
Slide 127
127
Slide 128
128
Slide 129
129
Slide 130
130
Slide 131
131
Slide 132
132
Slide 133
133
Slide 134
134
Slide 135
135
Slide 136
136
Slide 137
137
Slide 138
138
Slide 139
139
Slide 140
140
Slide 141
141
Slide 142
142
Slide 143
143
Slide 144
144
Slide 145
145
Slide 146
146
Slide 147
147
Slide 148
148
Slide 149
149
Slide 150
150
Slide 151
151
Slide 152
152
Slide 153
153
Slide 154
154
Slide 155
155
Slide 156
156
Slide 157
157
Slide 158
158
Slide 159
159
Slide 160
160
Slide 161
161
Slide 162
162
Slide 163
163
Slide 164
164
Slide 165
165
Slide 166
166
Slide 167
167
Slide 168
168
Slide 169
169
Slide 170
170
Slide 171
171
Slide 172
172
Slide 173
173
Slide 174
174
Slide 175
175
Slide 176
176
Slide 177
177
Slide 178
178
Slide 179
179
Slide 180
180
Slide 181
181
Slide 182
182
Slide 183
183
Slide 184
184
Slide 185
185
Slide 186
186
Slide 187
187
Slide 188
188
Slide 189
189
Slide 190
190
Slide 191
191
Slide 192
192
Slide 193
193
Slide 194
194
Slide 195
195

About This Presentation

this topic will illustrates and help the people to understand the knowledge regarding cardio vascular system disease condition.


Slide Content

CARDIOVASCULAR
DISEASES
Dr Sharad Chand Gupta
1

1) Introduction
2) Diagnosis of Cardiovascular
diseases
3) Causesofcardiovasculardiseases
4) Hypertension
5) CoronaryArteryDiseases(ischemic)
2
CONTENTS

6) Anginapectoris
7) MyocardialInfarction
8) Rheumaticfever
9) Rheumaticheartdiseases
10) HeartFailure
11) CardiacArrhythmia
12) OralHealthConsideration&OralManifestation
13) Oral Procedures & Need For Antibiotic
Prophylaxis To Minimise Risk Of Bacterial

Endocarditis
3

14) Pregnancyandcardiovasculardiseases
15) CongenitalCardiovasculardiseases
16) Studies involving cardiovascular diseases
and dentistry
15)Summary&Conclusion
15)References






4

 Cardiovasculardiseases(CVD)compriseofagroupofdiseas
es of heart and the vascular system.
 30.5% of all deaths takes places globally according to the
global and regional estimates for 2008.
 Compared with all other countries, India suffers thehighest
loss, due to dealths from CVDin people aged 35-64 years.
 TheprevalenceofCVDis2-3timesmoreinurbanthan
rural.
5
INTRODUCTION

 On the Indian subcontinent and in Africa, it is
predominantly due to rheumatic fever, whereas
calcificaorticvalvediseaseisthemostcommon
problem in developed countries.
 Withover3milliondeathsowingtoCVD
everyyear,Indiaissettobethe“HEART
DISEASECAPITALOFTHEWORLD”in
fewyears,saiddoctorsontheeveofWORLD
HEARTDAY(Sept.29th2010).

6

 Prompt recognition of the development of
heartdiseaseislimitedbytwokeyfactors:
1) Firstly,itisoftenlatent.
2) Secondly, the diversity of
symptomsattributable to heart disease
is limited.

7

Hypertension

CoronaryArtery
Disease
Myocardial
Infarction
Acutecoronary
Syndrome

CVD
Rheumatic heart
disease & fever

CardiacArrythmia

AnginaPectoris

Stroke

CongenitalCV
Disease
CongestiveHeart
8
Failure

DIAGNOSIS

OFCARDIOVASCUL
ARDISEASE

9

1) Symptomsandhistoryofpresentingillness

2) Pasthistory

3) FamilyHistory

4) PersonalHistory

10
SCHEMEOFHISTORY TAKING

SYMPTOMSANDHISTORYOF
PRESENTINGILLNESS
1. Dyspnoea
2. ChestPain
3. Palpitation
4. Syncope
5. CoughWithExpectorationAndHaemoptysis
6. Cyanosis
11

7. RightHypocondrialPain,SwellingOfFeetAnd
DecreaseInTheUrineOutput

8. GastrointestinalSymptomsLikeAnorexia,Full
ness Of Abdomen And Vomiting
9. Fatigability

10. Fever
11. DiabetesMellitusAndHypertension
12

PASTHISTORY
1. RheumaticFever
2. CyanoticSpells
3. RecurrentRespiratoryInfectionsSinceChildhood
4. DetectionOfMurmur/CardiacLesionAtSchool
5. Recent Dental Extraction, Genitourinary
Instrumentations
6. Hypertension,Diabetes Mellitus,IschaemicHeart
DiseaseOrAnyOtherSignificantMedicalIllness
7. Nifedipine-GingivalHyperplasia
13

FAMILYHISTORY

1. Hypertension
2. IschaemicHeartDisease
3. CongentalHeartDisease
4. RheumaticHeartDisease
5. SuddenDeath




14

PERSONALHISTORY

1. Appetite
2. WeightLoss
3. DisturbedSleep
4. BowelAndBladderDisturbances
5. Habits- Smoking And Alcoholism
6. ExposureToSyphilis



15

APPROACHTOA PATI
ENTOFCARDIACDISE
ASE









16

ANALYSISOFPRESENTING
SYMPTOMS



DEFINITION:-
 Abnormalawarenessofbreathingwithdiscomfort.
 Dyspnoea is a significant manifestation of
cardiacfailure.
 Dyspnoeaismorecommonlyduetoleft-sided
cardiacfailurethanduetorightheartfailure.


17

SEVERITY (GRADING)
:FUNCTIONALGRADINGOFDYSPNOEA
GRADE I : No limitationn of any physial activity but
dyspnoea occurs on more than ordinary (unoccustomed)
exertion.
GRADE II: Dyspnoea on ordinary daily activity
GRADEIII:Dyspnoeaonlessthanordinarydaily
activities.
GRADEIV:Limitationsofallactivities(dyspnoeaatrest)



18

Mechanismunderlyingdyspnoea:
 During Heart Failure Interstitial pulmonary
edema stimulates the J receptors reflex
rapidandshallowbreathing.
 Respiratorymusclefatigue
 Bronchialmucosaledema
 Increasedbronchialmucosalproduction

19

 ParoxysmalNocturnalDyspnoea(PND)
 Thisisanattackofsevereshortnessofbreathand
coughing usually occurring at night.
 Awakeningthepatientfromsleep.
 Persistaftersittingupright.
 May be due to depression of the respiratory centre at
night.
 Reduced adrenergic stimulation to the myocardium
at night.
20

Definition:

 Dyspnoeathatoccursusuallyonlyingdown/recumbentposition.

Characteristicfeatures:

 Usuallyoccurswithinminutesofassumptionofrecumbency.

 Occurswhenapatientisawake.

 Indicates the presence of severe left heart failure (pulmonary
oedema).
 Manifestslater than PND.(in slowlyprogressiveleftheart disease).
21

 Dyspnoeaoccursonsitting(upright)ratherthanon
lying down position.
 Example:leftatrialmyxoma,leftatrialballvalve
thrombus.






22

 Occurs on breathlessness only when lying
downin lateral/decubitus position.
 May be due to ventilation perfusion relationship
alteration in certain body position.
 Occur in patients with pathology of one
lungand chronic congestive heart failure.

23

 There is severe periods characterised by alternating
hypopnoea and hyperpnoea follwed by periods of
apnoea sign ofsevere heart failure.
 The patient lies motionless for 10-20 seconds and
again the cycle is repeated.
 Conditions associated : HF, Increased intracranial
pressure,Uraemia,Severepneumonia,Chronic
hypoxia,Narcoticdrugpoisoning,Cerebraltrauma
and haemorrhage, Normal subjects livingathigh
altitudes.
24

25

 Bluishdicolorationofskinandmucousmembrane.
 Resulting from increased amount of reduced
haemoglobin.
 Cyanosis appearing in infancy indicates the presence
ofcongenital cardiac anomalies with right to left
shunt(teratology of fallot).
 Cyanosisbeginningtoappearafter6weeksofagemaybe an
indication of VSD with slowly progressive right
ventricuaroutflowobstruction.
 Historyofcyanosisinasuspectedpatientofcongenital
heartdiseasebetween theage of5-20yearsindicates reversal
of left to right shunt (Eisenmeger Syndrome).
26

27

 Rightheartfailurecausessystemicvenous
congestionwithincreasedhydrostatic
pressureinthelowerlimbveins.Thisresults
inthetransudationoffluidcausingedema.
 Ankle edema is more common in
ambulatorypatients. Bed-ridden patient
develop sacral edema.
28

29

 This is due to enlarged and congested liver and
stretchingof its capsule, as in congestive heart failure.
 Cardiac pain may occasionally present as upper
abdominal pain.
 Pain from a dissecting abdominal aortic aneurysm isusually
most marked in the back and may originate in thechest
and spread down the legs. Other arteries can have
aneurysms and bleed.

 Inthe presence ofcardiac failure due todecreased cardiac
output, renal blood flow decreases with decrease in the
glomerular fitration rate, this causes decrease of urine
output in patientswithcardiac failure.

 Transientlossofconsciousnesswithposturalcollapse.

 Expectoration (coughing up) of blood or of blood-
stained sputum.

 Suggests uncomfortable awareness of heartbeat, which
may be unpleasant.

30

EXAMINATIONO
F
CARDIOVASCUAR SYSTE
M
31

1) Generalexamination
2) Externalmarkersofcardiacdisease
3) Examinationofperipheralcardiovascular
system
4) Examinationofprecordium
5) Examinationsincludingvariousother signs
6) Examinationsofface
7) Examinationsofmouth
8) Examinationsofear
9) Examinationsofeyes
10) Examinationsoffingers 32

GENERALEXAMINATION
1. Build
2. Nourishment
3.Pallor
4.Cyanosis
5. Clubbing
6. Jaundice
7. PedalOdema
8. Lymphadenopathy



33

PALLOR
 Severe anemiamaybe associatedwith:
1. ChronicCCF
2. Infectiveendocarditis
 Severe anemia can itself cause- cardiac failure or
aggravate the underlying heart disease.
 Patients with cyanotic congenital heart disease may
have polycythemia with suffused conjunctiva.




34

CYANOSIS

 Centralcyanosisoccursin:
[Decreasedatrialoxygensaturation]
1. Cyanoticcongenitalheartdisease
2. Reversaloflefttorightshunt(Eisenmenger’ssyndrome)
3. TetralogyofFallot
4. Pulmonaryedema(leftheartfailure)

 Peripheralcyanosisoccursin:
[Diminished peripheral blood flow = Reduced
Cardiacoutput]
1. Congenitalcardiacfailure
2. Peripheralvasculardisease
3. Shock
35

 Differentialcyanosis:
• Feetand toes are bluebut hands and fingers are
not cynosed.
• e.g. PDA with pulmonary hypertension with
reversal of shunt.

 Reversedifferentalcyanosis:
• Fingersaremorecyanosedthantoes.
• e.g.Transposition of great vesselswith
pulmonaryhypertensionwithpreductal
coarctationwithreversedflowthroughPDA.







36

CLUBBING

CARDIACCAUSES:

1. Cyanoticcongenitalheartdisease
2. Reversaloflefttorightshunt
3. Infectiveendocarditis

 Clubbingoffingersalsoknownasdrumstickfingersandwatch-glassnails.

 Clubbingdevelopsinfivesteps:
1) Fluctuationandsofteningofthenailbed.
2) Loss of the normal <165° angle (Lovibond angle) between the nailbed and the
fold (cuticula).
3) Increasedconvexityofthenailfold.
4) Thickeningofthewholedistal(endpartofthe)finger(resemblinga
drumstick).
5) Shinyaspectandstriationofthenailandskin.
37

JAUNDICE

Following cardiac conditions may be
associatedwith jaundice:
1. Congestivecardiacfailurewithcongestive
hepatomegaly
2. Cardiaccirrhosis
3. Pulmonaryinfarction












38

39
PEDALEDEMA
Pittingedemaoffeetcanoccurin:
1. congestivecardiacfailure
2. constrictivepericarditis
3. tricuspidvalvedisease
LYMPHADENPATHY
 Condition associated with
generalizedlymphadenopathy
mayinvolve thecardiovascular system.
 e.g.lymphoma,SLEetc.

EXTERNALMARKERSOF
CARDIACDISEASE
VITALSIGNS
• Pulse
• BloodPressure
• RespiratoryRate
• Temperature
RADIALPULSE
• Rate
• Rythm
• Volume
• Character
40

EXAMINATIONOF

• The Carotids & Jugular Venous Pulse And
Pressure
• PeripheralSignsOfInfectiveEndocarditis
• PeripheralSignsOfRheumaticFever










41

JugularVenousPulse































42

43

44

EXAMINATIONOFTHEPRECORDIUM
INSPECTION
1. PrecordialBulge
• PositionOfApicalImpulse
Pulsations In The:-
A. LeftParasternalRegion
B. 2
nd
LeftIntercostalSpace
C. 2
nd
RightIntercostalSpace
D. EpigastricPulsation
E. SuprasternalPulsation
F. EngorgedVeinsOverTheChest
G. Spine(kyphoscoliosis)
45

PALPATION

• PERCUSSION
1) RightCardiacBorder
2) LeftCardiacBorder
3) Left And Right 2nd
Intercostal Space.
46

AUSCULTATION
• Mitral, Tricuspid, Aortic, Pulmonary
AndOther Additional Areas For:-
A) 1
st
And2
nd
HeartSounds
B) AdditionalSounds
C) Murmurs
47

EXAMINATIONOFFACE
FollowingFeaturesMayBeIndicativeOfUnderlyingCardiacAbnormality
While Examination Of Face :

ABNORMALITIES CLINICALMANIF
ESTATIONS
CONDITIONS
ASSOCIATED
ELFINFACIES Recedingjaws,
Flarednostrils,
Pointedears
Supraventricular
aorticstenosis
HIGHARCHED
PALATE
Marfansyndrome
MITRALFACIES Malar flush and
pinkish purple
patchesoverthe
cheek
Mitral stenosis with
decreasedcardiac
outputandSystemic
vasoconstriction
48

MALARFLUSH












MARFANS
YNDROME
TERATOLGYOF
FALLOT










49

EXAMINATIONOFMOUTH
Acutemacroglossia:
The tongue is diffusely enlarged and
brightredalongitslateralportion.The
patienthadbleedingintothetongue while
on anticoagulants.



Acutemacroglossia
Due to Enalapril: this 75-year-old Black
femaledeveloped acute swelling of tongue and lips
after being on enalapril for 2 days. She was unable to
talk or swallow (upper photo).
In lower photo, 2 days after stopping enalapril, the
tongueandlipshavereturnedtotheirnormalsize.



50

GUMHYPERPLASIA
Due to dilantin. similar findings
maybeseeninpatientson
nifedipine




TANGIER DISEASE OF
THETONSILS:
Thetonsilsareenlargedwith
brightorange yellow streaks
(“tigerstripes”)(prematurecad).




51

EXAMINATIONOFEYES:

• Exopthalmus:associatedwiththyroidartery
disease.
• Bluesclera:Osteogenesisimperfectawithaorticregulation.
• Opthalmicfundus:looks for
a. Arterioscleroticchanges
b. Hypertensiveretinopathy
c. Roth’sspots(ofinfectiveendocarditis)
d. Corkscrewarteries-coarctationofaorta.
ROTHSSPOT
BLUESCLERA

52

EXAMINATIONOFFINGER



CLUBBING







CLUBING
NEGATIVE


53

OSLERSNODEINENDOCARDITIS


SUBUNGALHAEMORRHAGES

JANEWAYLESIONS




54

CAUSESO
F
CARDIOVASCLAR
DISEASE







55

1. MYOCARDIAL
A. OverloadSecondaryTo HypertensonOr Valve
Disease
B. Coronary(Ischaemic)HeartDisease
C. Cardiomyopathies
2. ENDOCARDIAL
A. RheumaticHeartDisease
B. CongenitalAnomalies
C. InfectiveEndocarditis
3. PERICARDIAL
A. Pericarditis
B. PericardialEffusion
C. FunctionalDisorders


56

 DUETOHYPERTENSION
 DUETOABNORMALITIESINHEARTRATE
A. Tachycardia
B. Bradicardia
C. OtherDysrthymias
 CHANGESINCIRCULATORYVOLUME
A. Hypovoloemia(ShockSyndrome)
B. Hypervolaemia(CirculatoryOverload)
C. Others
 CONGENITALABNORMALITIES:
1) Patentductusarteriosus
2) Ventricularseptaldefect
3) Arterialseptaldefect
4) TetralogyofFallot,etc.
57

FUNCTIONALCAPACITY
OBJECTIVE
ASSESSMENT
CLASSI.Patients With Cardiac Disease ButWithout
ResultingLimitation Of Physical Activity. Ordinary Physical
Activity
DoesNotCauseUndueFatigue,Palpitation,Dyspnea,Or
Anginal Pain.
A. No Objective
Evidence Of
Cardiovascular
Disease.
CLASS II. Patients With Cardiac Disease Resulting In
SlightLimitationOfPhysicalActivity.They Are ComfortableAt
Rest. Ordinary Physical Activity Results In Fatigue,
Palpitation, Dyspnea, Or Anginal Pain.
B. Objective Evidence
Of Minimal
Cardiovascular
Disease.
CLASSIII.Patients
WithCardiacDiseaseResultingInMarkedLimitationOf
PhysicalActivity. They Are Comfortable At Rest. Less Than
Ordinary Activity Causes Fatigue, Palpitation, Dyspnea, Or
Anginal Pain.
C. Objective Evidence
Of Moderately
Severe
Cardiovascular
Disease.
NYHACLASSIFIACTION

CLASSIV.PatientsWithCardiacDiseaseResultingInInability
To Carry On Any Physical Activity Without Discomfort.
SymptomsOfHeartFailureOrTheAnginalSyndromeMay Be
Present Even At Rest. If Any Physical Activity Is
Undertaken,DiscomfortIsIncreased.
D. Objective Evidence
Of Severe
Cardiovascular
Disease.
58

59
HYPERTENSION

CONTENTSOFHYPERTENSION
 Definition
 Classification
 Types
 Otherriskfactors
 Effectsofhypertension
 Complications
 Symptoms
 Oralmanifestations
 Diagnosis
 Whitecoathypertension
 Dentalmanagement
 Treatmentofhypertension
 Oralmedicationsused
 Conclusion
60

HYPERTENSION
 HypertensionisknownasSilentKillerofmankind.

 Most of the sufferers (85 %) are asymptomatic and
hence early diagnosis is a problem.

 Normal or optimal blood pressure (BP) is defined
asthelevelabovewhichminimalvasculardamage occurs.
There is a continuous, consistent, and independent
relationship between elevated BP and risk of
cardiovascular events.

61

Definition
• Hypertensionisusuallydefinedbythepresenceofachronic
elevation of systemic arterial pressure above a certain threshold
value.*
• AccordingtoDavidson:

• Hypertensionisdefinedashavingsystolicbloodpressure(SBP)
>/=140mmofHg.
(or)
Diastolicbloodpressure(DBP)>/=90mmofHg. (or)
Ashavingtouseantihypertensivemedications.

*ThomasD.Gilesetal.DefinitionandClassificationofHypertensio
n: An Update ; Emerging concept : 2009, 11:611–614.
62

The Seventh Joint National Committee Criteria
(JNCVII)classifies hypertension for adults aged
18yearsandolderintofollowingstages:

BloodPressureClassification SBP(mmHg) DBP(mmHg)

• Normal <120 & <90
• Prehypertension 120-139 & 80-89
• StageIhypertension 140-159 & 90-99
• StageIIhypertension >/=160 & >/=100
• IsolatedSystolichptn. >140 & <90
63
CLASSIFICATION

• “For individuals 40-70 years of age, each increment of
20mmHginsystolicBPor10mmHgindiastolicBPdoublesth
e riskof CVD across the entire BP rangefrom 115/75 to
185/115 mmHg”. [JNC VII. JAMA 2003;289:2560-2572 ]

ClassificationaccordingtoWHO
• GradeI:Hypertensionwithoutdamagestotheend
organ.
• Grade II: Hypertension with damages to the
endorgan(e.g..fundushypertonicus(GradeIandII),p
laqueformationinthelargerbloodvessels)
• GradeIII:Hypertensionwith
manifest cardiovascular secondary diseases
(e.g. angina pectoris,heart attack, stroke)
64

TYPES


PRIMARY(or)ES
SENTIALHYPERT
ENSION

• Which develops
graduallyovermany
years & has no
underlyingcause.

• 90% of people have this
type of hypertension
SECONDARYH
YPERTENSION


• Whichhasanunderlying
cause such as renal
disorders, endocrinal
disturbances, neurologic
causes etc.

• 10%ofpeoplehavethis
type of hypertension.
65

OtherRiskFactorofHypertension
• Lackofexercise
• Increasedsaltintake
• Familyhistory
• Toolittlepotassium
• Alcohol
• Smoking
• Stress&
• Age

66

67
EffectofHypertension
The common target organs damaged by long
standing hypertension are:

• Brain
• Heart
• Kidneys
• Eyes &
• Peripheralarteries.

Complicationsofhypertension

 Leftventricularhypertrophy
 Heartfailure
 Cerebralhemorrhage
 Renalinsufficiency
 Aorticdissection
 Atheroscleroticdisease


68

Symptoms
Symptomsduetohypertension:
1. Headache-usuallyinmorninghours.
2. Dizziness
3. Epistaxis

Symptomsduetoaffectovertargetorgans:
1. CVS:
a. Dyspneaonexertion
b. Anginalchestpain
c. Palpitations



69

2. Kidneys:Hematuria,nocturia,polyuria.
3. CNS:
a. Transientischemicattacks(TIAorStroke)
b. Hypertensive encephalopathy(headache ,
vomiting etc.)
c. Dizziness,Tinnitus&syncope.
4. Retina:
a. Blurredvisionor
b. suddenblindness.




70

Diagnosis
• PhysicalExamination
• Laboratory and Additional Testing – it includes
Routinelaboratoryprocedureslike
hemoglobin,urinalysis,routineblood
chemistriesandfastinglipidprofile.
• Electrocardiography&Electroencephaloghy
• AmbulatoryBPMonitoring
• Plasmareninactivitytesting
• Radiologictesting
71

WHITE
COATHYPERTENSI
ON
‘’White coat hypertension’’ is a
phenomenon in which
individualspresent with persistent
elevated BP in a clinical setting but
present withnon-elevated BP in an
ambulatory setting.

• 20% of mild hypertensive
individuals may present with
whitecoat hypertension.

72

DentalManagement
• MeasureandrecordBPatinitialvisit

























73

Recheck:-
• Every 2 yrs for patient with BP <120/80 mm
Hg.
• Every1yrforpatient with BP120-139/80-89
mm Hg.
• EveryvisitforpatientwithBP>140/90mm
Hg.
• Every visit for patient with established
coronary artery disease, diabetesmellitusor
chronic renal disease with BP >135/85 mm Hg.
• Everyvisitforpatientwithestablished
hypertension.
Beforeinitiatingdentalcare:
• Assesspresenceofhypertension
• Determinepresenceoftargetorgandisease
• Determinedentaltreatmentmodifications
74

1. Asymptomatic BP <159/99 mm Hg, no history of target
organ disease
• Nomodificationsneeded
• Cansafelybetreatedindentalsetting

2. Asymptomatic BP 160-179/100-109 mm Hg, no history of
target organ disease
• Assessmentonanindividualbasiswithregardtotypeofdental
procedureBP>180/110mmHg,nohistoryoftargetorgandisease
• NoelectivedentalcareuntilBPiscontrolled.

3. Presenceoftargetorgandiseaseorpoorlycontrolled
diabetes mellitus
• NoelectivedentalcareuntilBPiscontrolled,preferablebelow140-90
mmHg.
75

TREATMENTOFHYPERTENSION
Non Pharmacological
TreatmentLifestyle Modifications

1. Saltrestriction
2. Weightreduction
3. Stopsmoking
4. Dietmodificationssuchas:
• ReduceintakeofCholesterol&
Saturated fat.
• AdequateintakeofCalcium&M
agnesium.
76

5. Avoid/Limitofalcoholintake


6. Relaxationsuchasyoga,psychotherapyetc.



7. Regularexercise.




77

ORALMEDICATIONSUSEDFOR
TREATMENTOFHYPERTENSION
• Diuretics
• Beta-AdrenergicBlockers
• CentralActingInhibitors
• PeripheralActingInhibitors
• Non-Selectivealpha&betaAdrenergic
Inhibitors
• Vasodilators
• Angiotensin Converting Enzyme ACE
Inhibitors

78

ORALMANIFESTATIONOF
HYPERTENSION
There are no recognized manifestations of
hypertension but anti-hypertensive drugs can often
cause side affects ,such as:
• Xerostomia,
• Gingivalovergrowth,
• Salivaryglandswellingorpain,
• Lichenoiddrugreactions,
• Erythemamultiforme,
• Tastesensealteration,
• Paresthesia.
79

CONCLUSION
• HYPERTENSION has no cure, but it can be
controlled with proper diet, lifestyle changes,
andifnecessarymedications.
• Get regular health check ups. Think about
theconsequencesofuntreatedhighbloodpressure
.
• Do not take chances with the disease that can be
controlled.
• Lastly,Hypertensionisasilentdisease,butits
silenceisnot golden.

80

CORONARY
(ISHAEMIC) ARTERY
DISEASE













81

CORONARYARTERY DISEASES
1) Etiopathogenesis
2) Riskfactors
3) Diagnosis
4) Management
5) Dentalaspects

82

• Atherosclerosis is the most common cause of
CAD
ETIOPATHOGENESIS
Variousriskfactorsinclude:
1. lipids(especiallyHDL)
2. hypertension
3. diabetesmellitus&glucoseintolerance
4. cigarettesmoking
5. lifestyle&dietaryfactors
6. exercise
7. obesity
83

8. plasmafibrinogen
9. endothelialdysfunction
10. antioxidants
11. estrogendeficiency





















84

RISKFACTORS
Induce variety of pathological processes
Interaction & disruption of vascular
endotheliumPlaque formation
Effective arterial luminal area compromised
Myocardial ischaemia acuteplaquerupture
angina
thrombusformation
MI


85

86

87

DIAGNOSIS
1) Basedonclinicalpresentation:
 chesttightness
 Jawdiscomfort
 Leftarmpain
 Dyspnea
 Epigastricdistress
2) E.C.G.
3) ExerciseE.C.G.
4) CoronaryAngiography
5) P.C.I.(PercutaneousCoronaryIntervention)
6) Incaseofcomplicationslikestroke/shock–EEG
7) Recentdevelopment:Oneminuteangiogram
88

MANAGEMENT
ManagementofCADdependson:
• Extentandseverity ofischemia
• Exercisecapacity
• Prognosisbasedonexercisetesting
• OverallLVfunction
• Associatedfeaturessuchasdiabetesmellitus
 Patients with a small ischemic burden, normal
exercisetolerance, and normal LV function may be safely
treatedwith pharmacologic therapy.
 Selected useofaspirin, β-blockers, ACEIs,and
HMG CoA reductaseinhibitors.
 Nitrates and calcium channel blockers may be added
to primary agents to relieve symptoms of ischemia
inselected patients.
89

• SURGICAL
MANAGEMENT:
 Percutaneous coronary
intervention (PCI) with
percutaneous transluminal
coronaryangioplasty(PTCA)
and intra coronary stenting
relieves symptoms in
chronicishchemia.
90

• Patientwithcomplex
multivessel CAD require
PCI with medical
therapyof surgical
revascularization.

• PatientswithreducedLV
function and severe
ischemia, often associated
with leftmainor
multivessel CAD, are
bestserved by coronary
artery bypass graft
(CABG) surgery.


91

DENTALASPECTS
• STRESS,ANXIETY,EXERTIONorPAIN
canprovokeangina.
• Short,minimallystressfuldentalappointments.
• Latemorningappointments.
• ExcessivedoseofLAcontainingadrenalineto
beavoidedinpatientstakingbetablockers.
• More Common - severe dental caries and
periodontaldiseaseinptsofIHD.

92

93
ANGINAPECTORIS

• Namegiventoparoxysmsofseverechestpain
CLINICALFEATURES
1) 40TO60years,M>F
2) PainoftendescribedassenseofStrangling,choking,
Tightness, Heaviness ,Compression, or Constriction of
chest.
3) PAINMAYRADIATETOJAWorleftarm.
4) Rarelypaininmandible,teethorothertissues.

PRECIPITATINGFACTORS
• Physicalexertion(main)particularlyincoldweather
• Emotion(angeroranxiety)&stresscausedbyfearor
pain

 TYPICALLYRELEIVEDBYREST
94

Dentalaspects
 Preoprerative glyceryl trinitrate & oral sedation
advisedsometimes.
 Dental care carried with minimal anxiety &oxygen
saturation
 Monitorpulse&B.P.
 POSTANGIOPLASTYelectivedentalcaredefferedfor6
months,emergencydentalcareinahospitalsetting.
 Patients with BYPASS GRAFTS –anti bioticcover
against infective endocarditis .
-LAcontainingadrenalineis
contraindicated(maypptdysrhythmia)


95

 Patients with vascular stents – no
antibioticcover except during 1
st
6 week
postop for emergency dental care.

 DRUGS used in t/t of angina may cause
oraladverseeffectslike:
-lichenoidreaction Cachannel
-gingivalswelling blockers
-ulcers(nicorandil)






96

Gingival
hyperplasia in
patient consuming
Cachannelblockers











97

98
MYOCARDIALINFA
RCTION

• Synonyms–coronarythrombosisorheartattack
CLINICALFEATURES
1. Clinicalpictureisvariable
2. Morethan50%patients are symptomless
3. MImaybeprecededbyanginaoftenfeltasindigestion
likepain
4. anyanginalattacklastinglongerthan30minutesis
considered MI
5. Tachycardia&irregularpulse
6. Nausea,vomitting,sweating,restlessness,facialpallor
7. Breathlessness,cough
8. Lossofconciousness,shock&evendeath
9. Many pts die within 1
st
hour to few days after attack.
Thus,MIisaMEDICALEMERGENCY.




99

100

DIAGNOSIS
I. Basedonclinicalfeatures
II. ElevatedTLC&ESRduring1
st
wk
III. ECGchanges
IV. Riseinserum“cardiac”enzymes(CPK)
V. RiseintroponinTwithin4-
8hoursVI.Echocardiography






101

GeneralPrecautionsduringDentalProcedures

• Dentalclinicshouldhaveadvancedcardiaclifesupportorat
least basic cardiac life support.
• Useofpulseoximetertodeterminetheleveloxygenation.
• Automaticexternaldefibrillator.
• Determinationofvitalsignspriortodentalcare.
• BP&pulserate&rhythmshouldberecorded&any
abnormalfindingsshouldbeaddressed.
• Premedication with antianxiety drugs and inhalation nitrous
oxide in anxious patients.
• Elective procedures esp those requiring GA should
beavoidedforatleast4wksaftrMI.consult pt’s physician prior
to dental therapy
102

Managementondentalchair
1. Terminatealldentaltreatment
2. Positionptinsemireclineposition
3. Givenitroglycerin(TNG)(abt0.4mg)tabletorspray
4. Administeroxygen
5. Checkpulse&B.P.

Discomfortrelieved Discomfortcontinues3minsafter2
nd
TNG

6. Assume angina pectoris is 6. give 2
nd
TNG dose
present 7.monitorvitalsigns.
7. Slowly taper oxygen over
5 mins
8. Modifyt/ttopreventrecurrence discomfort discomfort
continues
relieved 3minsafterTNG




103

8. give3
rd
TNGdose
9. Monitorvitals
10. Callformedicalassistance

Discomfortrelieved discomfortcontinues3minsafter 3
rd
TNGdose

11. Referptformedical 12.assumeMIisinprogress
evaluationbefore 13.starti.v.linewithdripofacrystalloid
solution
furtherdentalcare at30mL/hr

14. Ifdiscomfortseveretitratemorfinesulphate2mgs/cori/vevery3mins
untilreliefisobtained
15. Transporttoemergencycare.AdministerBasicLifeSupport,if
necessary.

104

AnticoagulationTherapy&DentalCare
• Anticoagulant therapy is used both to treat & to
prevent throboembolism.
• 2majortypes:1.antiplateletmedications
2. antithrombinmedications
• Acetylsalicylic acid (ASA) +
clopidogrel(anticoagulant) given for 4
weeks after stent implantation.
• dailyaspirintypicallycontinuedlifelong.
• Mayincreaseriskoforalbleedingfollowingsurgical
procedures.
• Associated conditions which predispose patient to
uncontrolled hemostasis : uraemia or liver diseases or
use of NSAIDS.
• Ifemergencysurgeryneedstobedone,DDAVP(1-
desamino-8-D-arginine vasopressin)
isadministered{0.3 micro kg/body wt
parenterally}within1hrofsurgery.
105

• Antithrombin medications are dicumarols (
eg.Warfarin),itinhibitsbiosynthesisofvit.–K
dependent coagulations protein.

- Efficacy monitoredbyprothrombintimeorthe
international normalized ratio (INR), which is
calculated on the basis of international
sensitivityindex(ISI).
- INR ranges from 2.0 – 3.5 & it should be performed
within 24 hrs of surgery.
- If INR is < 3.5, anticoagulation therapy should be
discontinued before minor surgical procedures.

106

 3 different protocols used to treatpatientswith
elevated INR :

• Ist protocol– warfarin not discontinued
(minimizes thromboembolic events &
increasesriskofbleedingaftersurgery).

• IInd protocol– warfarin discontinued (drug
shouldbe discontinued 2-3 days prior to surgery,
during this period patient is at risk of developing
thromboembolic event but not bleeding).

• IIIrd protocol– warfarin discontinued &
patientplaced on alternative anticoagulant
therapy (thromboemboliceventminimized).
107

108
RHEUMATICFEVER

• Rheumaticfeverisaninflammatorydisease
that may develop two to three weeks after a
GroupAstreptococcalinfection(suchasstrep
throatorscarletfever).Itisbelievedtobe
causedbyantibodycross-reactivityandcan
involve the heart, joints, skin, and
Brain.
• Acute rheumatic fever commonly appears
inchildren ages 5 through 15, with only 20% of
first timeattacksoccurringinadults.

109

110

• Whatare the symptomsof strep
throat?
• Sudden onset of sore throat
(streptococcal oropharyngitis)

• Painonswallowing
• Fever,usually101–104°F
• Headache
• Redandedematoussoftpalateand
oropharynx.

• Areasoftonsillarulcerationand
exudation.

• Abdominal pain, nausea and
vomiting may also occur,
especially in children.



111

 What are the symptoms/clinical features of
rheumatic fever?

Symptomsmayinclude:
• fever
• painful,tender,redswollenjoints
• paininonejointthatmigratestoanotherone
• heartpalpitations
• chestpain
• shortnessofbreath
• skinrashes
• fatigue
• small,painlessnodulesundertheskin



112

113

• Minorcriteria
• Fever
• Arthralgia
• Laboratoryabnormalities:increased
Erythrocyte sedimentation rate
• Electrocardiogramabnormalities
• Evidence of Group A Strep infection:
elevatedorrisingAntistreptolysinOtitre.







114

LABINVESTIGATIONS
• RaisedESR
• Culture studies of throat
swabsisalwaysnegativein
RF.
• High anti sterptolysin
o(ASO)titre-300 micro
units
• Chest radiograph-
enlargementofheart
• ECG-prolongedPR
interval
• Echocardiogram-confirms
ventricular dilatation n
pericardial effusion


115

• TREATMENT:

• Oralphenoxymthylpenicillin500mguntilage
of 20 yrs.
• Allergic to penicillin,sulfadimidine by
mouth.
• Aspirin for fever and pain 50mg/kg in 4 hrly
doses
• Corticosteroids60-80mgprednisolone
• Digoxinanddiureticsforheartfailure
• Ballonvalvuloplasty,usinginoueballoon,if
mitral valves damage.

116

DENTALCONSIDERATION

• Dental extractions and local
anesthesia in consent with
physician.
• Theprophylacticuseof
antibiotics prior to a dental
procedure is now
recommended ONLY for
those patients with the
highest risk of adverse
outcome resulting from
endocarditis.
• GA should be avoided if
essentialmustbegivenin
hospital.


117

118
RHEUMATIC
HEARTDISEASE

Rheumaticheartdisease:

• History ofrheumatic feverduringchildhoodor
adolescence can act as a predisposing
factorforRHDafterseveralyears.
• Common signs-murmur
duetovalvulardamage n later
enlargement of heart.

119

120

ORALMANIFESTATIONS
• Most prominent during acute
phase
• Pharyngitis
• Incoraltemperature
• Distendedneckveinsanda
bluish color of the skin.





121

DENTALCONSIDERATIONS

• To prevent complication of infective
endocarditis ,all dental procedures should be
carriedunderantibioticcover.

• Amoxicillin prophylaxis-1 hour beforeand
6hours after the initial dose.

• Good oral hygiene measures ,fluoride
treatment, chlorhexidine rinses and routine
cleaningsto reduce harmful bacteremias.

122

• Proper history should be taken to
identifyhistoryofrheumaticfeverduringchildh
ood.

• Suspicious cases should be referred to
cardiologist for cardiac evaluation prior to
dental procedures.

• Clindamycin or erythromycin prophylaxis
duringdentaltreatment.

• Elective dental treatment under physician
consultation.

123

124
HEARTFAILURE

HEARTFAILURE

• Heart failure (HF) is a
condition in which a
problemwiththestructure
orfunction of the heart
impairsitsability tosupply
sufficient blood flow to
meetthebody'sneeds.
• Commoncausesofheart
failure–
• ischemicheartdiseases
• Hypertension
• Valvulardiseases


125

Left-sidedfailure(MORECOMMON)

• Failure of the left ventricle causes congestion of the
pulmonaryvasculature,andsothesymptomsare
predominantlyrespiratoryinnature.Thepatient
willhavedyspnea(shortnessofbreath)onexertion
and in severe cases, dyspnea at rest.
Increasingbreathlessnessonlyingflat,called
orthopnea.

• Another symptom of heart failure is
paroxysmanocturnal dyspnea also known as
"cardiac asthma", a sudden nighttime attack of
severe breathlessness, usually several hours after
going to sleep.


• Inadequate cerebral oxygenation leads to loss of
c
o

ncentration,restlessness and irritability.



126

Right-sidedfailure

• Failure of the right ventricle leads to
congestion of systemic capillaries. This
helpsto generate excess fluid accumulation in
the body. This causes swelling under the
skin(termed peripheral edema or anasarca)

• If occurswith Mitralstenosisis called
congestiveheartfailure.

127

• Biventricularfailure,faiure
ofonesideofheartleadsto
failure of other.

CLINICALFEATURES
• Pedaledema
• Dyspnea
• Congestionofneckveins
• Cynosis
• Fatigue
128

DIAGNOSIS

• Imaging
Echocardiography
• Electrophysiology
electrocardiogram
(ECG/EKG)
• Bloodtests
• Angiography
• Monitoring





129

TREATMENTMODALITIES

• Dietandlifestylemeasures
• Weightreduction
• Monitorweight
• Sodium restriction -excessive sodium intake
mayprecipitate or exacerbate heart failure
• Fluid restriction – patients with CHF have a
diminished ability to excrete free water load.
• stressreduction,rest
• Stopsmoking




130

Pharmacologicalmanagement
• Diuretic
• Loopdiuretics(e.g.furosemide,bumetanide)

• ACEinhibitor/AngiotensinIIreceptorantagonistPositi
ve inotropes
• Digoxin
• Betablockers
• Alternativevasodilators
• Thecombinationofisosorbiddinitrate/hydralazine


131

ORALMANIFESTATIONS


• Distentionoftheexternal
jugular viens.

• Compensatory polycythemia
–ruddy complexion and
bleeding tendencies.

• Abnormalproductionof
clotting factors

• Bleedingcanbespontaneous
orextravasational.













132

DENTALASPECTS

• The dental chair should be kept in
partiallyreclining or erect position and patient
should be raisedslowlyinuprightposition.

• Emergency dental care should be conservative,
principallywithanalgesicsandantibiotics.

• Appointmentsshouldbeshort
• Nonstressfulappointments

• Patientsarebesttreatedinlate morningbecause of
epinephrinelevelspeakinearlymorning.
133

• Bupivacaineshouldbeavoidedasitis
cardiotoxic.

• Anaspiratingsyringeshouldbeusedtogive
localanesthetic

• Epinephrine containing LA should be not
given in large doses to patients taking beta
blockers.

• Gingival retraction cords
containingepinephrine should be
avoided

134

• SupplementalO2shouldbeavailable

• Rubber dam is contraindicated when it
contributestobreathingdifficulty.

• NSAIDSotherthanaspirinshouldbe
avoidedinptstakingACEinhibitors(renaldama
ge).

• Erythromycinandtetracyclinetobeavoided
as they may induce digitalis toxicity

135

• GAiscontraindicatedincardiacfailure.untilunder
control(venousthrombosisandpulmonary
embolism)

• ACEinhibitorscansometimescauseerythema
multiforme,angioedemaorburningmouth.

• Antibioticprophylaxisrequiredfordentalcare.

• History of recent MI ,required delay of
electivedental care for 6 months.

136

137
CARDIACARRHYTHMIA

CARDIACARRHYTHMIA:

• Cardiac arrhythmia (also
dysrhythmia) is a term for
any of a large and
heterogeneous group of
conditionsinwhichthereis
abnormalelectrical activity
in the heart.

• The heart beat may be too
fast or too slow, and may be
regular or irregular .

• Accordinglythereare2types
:
1) Atrialarrhythmia
2) Ventriculararrhythmia





138

• TACHYCARDIA :Anyheartratefasterthan
100 beats/minute is labelled tachycardia.

• BRADYCARDIAS:Aslowrhythm,(lessthan
60 beats/min), can lead to syncope.

• HEART BLOCK:Blockage of cardiac
impulseanywhereintheconductionsystem.
139

140

TREATMENT



AA:
• Digoxin
• Propanolol
• Quinidinesulphate
• Anticoagulantsuchas
warfarin
VA:
• Procainamide
• Phenytoin
• Dispyramide
• Propanolol










141

• Physicalmaneuvers
• Antiarrhythmicdrugs
• Electricity
• Electricalcautery


142

ORALMANIFESTATIONS

• Procainamide can cause
agranulocytosis,oral
ulcerations.

• Quinidine-infrequentoral
ulcerations.

• Disopyramide is
anticholinergic agent capable
of producing xerostomia.

• verapamil,enalapril can cause
gingival hyperplasia.



143

DENTALCONSIDERATION
S
• Aproperhistorytobe
taken.
• Stressandanxiety
be minimized.
• Shortappointments
• Use of epinephrine to be
minimized.
• Properchairpositionis
important,SUPINE.
• At end of appointment
chair should be raised
slowly to minimize
orthostatic hypotension.



144

• Use of vasoconstrictors should be
minimizedinptstakingdigitalisglycosides.

• The equipments like pulp testers
,ultrasonicscalers ,electrosurgical units
,should not be in closeproximity.

• Prophylactic antibiotics before and after
treatment in recently placed pacemaker
patients.



• Pts who report palpitations or skipped beats
mustbeevaluatedbyphysician.




145

• Sustained sinus tachycardia above 100
beats/min inrestingposition
isindicativeofsinus tachycardia.
• Dental treatment shd not be carried out in
patients withirregularpulse.
• Long use of procainamide can cause a lupus
like syndrome.
• Druglikequinidinecancauseerythema
multiforme.
• CAmaybeinducedbygeneralanesthesia
and vagal reflex.
146

147
ORAL
HEALTHCONSIDERATION
& ORALMANIFESTATION

• Valvular heart disease that compromises cardiac output
produces signs of hypoxemia.

• Cyanosisoflipsandoralmucosaisthemostprominentoral sign
of tissue hypoxia.

 AccordingtoAmericanheartassociationguidelines:
• Antibiotic prophylaxis should be administered to
patientswho have undergone mitral or aortic valve repair
or replacement.
• Patientswithapriorhistoryofinfectiveendocarditis.
• Patientswithmitraloraorticregurgigationorstenosis.
• Patientswithmitral valvularprolapsewithvalvular
regurgigation.
148

• Prostheticheartvalves.
• Previousbacterialendocarditis.
• Acquiredvalvulardysfunction.
• Complexcyanoticcongenitalheartdisease.
• Surgicallyconstructedsystemicpulmonary
shunts.






149

ORALPROCEDURES&NEEDFOR
ANTIBIOTIC PROPHYLAXIS TO
MINIMISERISKOF
BACTERIALENDOCARDITIS


• Extractions.
• Periodontal procedures including surgery,subgingival,placement
of antibiotic fibers or Strips,scaling &root planning.
• Implantplacement.
• Toothreimplantation.
• Placementoforthodonticbands(notbrackets).
• Endodonticinstrumentation.
• Intraligamentaryinjection.
• Prophylaticcleaningofteethwherebleedingisanticipated.
• Otherprocedureinwhichsignificantbleedingisanticipated.

150

STANDARDREGIMENSFORPROPHYLAXIS
TO MINIMISE RISK OF
BACTERIALENDOCARDITIS


• Oralmedication.
• Adults&childrennotallergictopenicillin-amoxicillin.
• Adults&childrenallergictopenicillin-clindamycin.
• Nonoralmedication.
• Adults&Childrensnotallergictopenicillin-ivorim
ampicillin.
• Adults&childrenalergictopenicillin-ivclindamycin.





151

152

153

PREGNANCY
&CARDIOVASCULA
RDISEASES











154

• Diagnosis of congenital cardiac
malformationscan be made as early as 13
weeks, and, in families with heart disease.
• Early examination in pregnancy allows parents
toconsideralloptions,includingterminationof
pregnancy,iftherearemajormalformations.
• Hypertensive disorders during pregnancy
occurin women with pre-existing primary
orsecondary chronic hypertension, and in
women who develop new-onset hypertension in
the second half of pregnancy.
155

156

157

158
CONGENITAL
HEARTDISEASES

• Congenital heart disease usually manifests in
childhood but may pass unrecognised and not
present until adult life.
• The fetus has only a small flow of bloodthrough
the lungs, as it does not breathe in utero. The
fetal circulation allows oxygenatedblood from
the placenta to pass directly to the left side of
the heart through the foramen ovale
withouthavingtoflowthroughthelungs.
159

PersistentDuctusArteriosus
• During fetal life, before the lungs begin
tofunction, most of the blood from the
pulmonary artery passes through the ductus
arteriosus into the aorta.
• Normally, the ductus closes soon after
birthbut sometimes fails to do so.
• Since the pressure in the aorta is higher than
that in the pulmonary artery, there will be a
continuous arteriovenous shunt.
160

161

Management:
• Apatentductusisclosedatcardiac
catheterisation with an implantable occlusive
device.
• When the ductus is structurally intact,
aprostaglandin synthetase inhibitor
(indometacinor ibuprofen) may be used in the
first week
oflifeandalsoimprovingoxygenationtoinduce

closure.
162

Coarctationoftheaorta

• Narrowing of the aorta occurs in the
regionwhere the ductus arteriosus joins the
aorta, i.e. at the isthmus just below the origin
of the left subclavian artery.
• Management : In untreated cases, death may
occur from left ventricular failure, dissection
ofthe aorta or cerebral haemorrhage.
163

Atrialseptaldefect

• ‘Ostiumprimum’defectsresultfromadefectin
the atrioventricular septum and are associated
witha‘cleftmitralvalve’(splitanteriorleaflet).
• As a result there is gradual enlargement of the
right side of the heart and of the pulmonary
arteries.
164

165

• Management : Closure can also be
accomplished at cardiac catheterisation using
implantable closure devices.
• Severe pulmonary hypertension and shunt
reversal areboth contraindications to surgery


166

Ventricularseptaldefect

• Congenital ventricular septal defect occurs as a result
of incomplete septation of the ventricles.
• Management:Smallventricularseptaldefects
requirenospecifictreatment.Cardiacfailurein
infancy is initially treated medically with digoxin
anddiuretics.Persistingfailureisanindicationfor
surgical repair of the defect. Percutaneous closure
devices are under development.
167

168

TetralogyOfFallot




























169

170

171

STUDIES
SHOWINGASSOCIATIONOFPE
RIODONTITISANDCARDIOVA
SCULARDISEASES










172

Periodontalinfectionsand cardiovascular
disease.Theheartofthematter

• Journal:TheJournaloftheAmericanDentalAssociation(October2006)1
37,14S-20S.
• Author:RyanT.Demmer
• Conclusions. Evidence continues to support an association
amongperiodontal infections, atherosclerosis and vascular disease.
Ongoing observational and focused pilot intervention studies may inform
thedesign of large-scale clinical intervention studies.
Recommendingperiodontal treatment for the prevention of
atherosclerotic CVD is notwarranted based on scientific evidence.
Periodontal treatment must be recommended on the basis of the value
of its benefits for the oral health of patients, recognizing that patients are
not healthy without good oral health. However, the emergence of
periodontal infections as a potential riskfactorfor CVD
isleadingtoaconvergenceinoralandmedicalcare that can only benefit the
patients and public health.

173

Associationbetweendentalhealthand
acutemyocardialinfarction.
• Journal:BMJ2009;298:779.
• Authors:K.J.Mattilaetal.
• Abstract
Knownriskfactorsforcoronary heartdiseasedonotexplainalloftheclinical and
epidemiological features of the disease. To examine the role of chronic bacterial
infections as risk factors for the disease the association between poor dental
health and acute myocardial infarction was investigated in two separate case-
control studies of a total of 100 patients with acute myocardial infarction and 102
controls selected from the community at random. Dental health was graded by
using two indexes, one of which was assessed blind. Based on these
indexesdentalhealth wassignificantly worsein patientswithacute myocardial
infarction thanincontrols. Theassociation remainedvalidafteradjustmentfor age,
social class, smoking, serum lipid concentrations, and the presence of diabetes.
Further prospective studies are required in different populations to confirm the
association and to elucidate its nature.
174

175
SUMMARY

176

• Cardiovascular problems are non-communicable
diseases which are growing in India and other
partsof the world very fast.
• The dental considerations for such cases are required
withproperinvestigationsandmedications.
LETSJOINHANDSFORSAVINGTHEHEARTS
OFTHENATION!

177
CONCLUSION

• Davidson’sPrincipleandPracticeofMedicine–
21
st
Edition
• Burket’sBookofOralMedicine–11
th
Edition
• Emerging risk factors for
cardiovasculardiseases:Indiancontext. Sushilet al.
Indian Journalof Endocrinology and Metabolism /
Sep-Oct 2013 /Vol 17 | Issue 5
• HeartDiseaseandStrokeStatistics--2010Update:A
Report From the American Heart Association

178
REFERENCES

• Oral Health, Atherosclerosis, And
Cardiovascular Disease. Jukka H. Meurman
EtAl.CritRevOralBiolMed;15(6):403-413
(2004).
• 2007 Guidelines For The Management
OfArterialHypertension.EuropeanHeartJou
rnal(2007)28,1462–1536.
• Dental Disease And Risk Ofcoronary Heart
Disease And Mortality. Frank Destefano Et
Al. Bmj Volume 306 13 March 1993.
179

• CoronaryArteryDisease.MuntherK.
Homoud.SeminarByMdOfTufts-new
EnglandMedicalCenterSpring2008.
• Hypertension In Pregnancy:the Management
Of Hypertensive Disorders During Pregnancy.
Royal College Of Obstetricians And
Gynaecologists. National Collaborating Centre
For Women’s And Children’s Health.Aug 2010.
• Relationship Between Oral Health Lars Frithiof
EtAl.JClinPeriodontol2001;28:762–768.

180

• DefinitionAndClassificationOfHypertension: An
Update. Emerging Concept.
ThomasD.GilesEtAl.TheJournalOfClinicalHypert
ension.Vol.11No.11November 2009.
• PreventionOfInfectiveEndocarditis:Guidelines
FromTheAmericanHeart
Association.AGuidelineFromTheAmericanHeart
Association.
• Dental Considerations In Patients With Heart
Disease. Marta Cruz-pamplona Et Al. J
ClinExpDent.2011;3(2):e97-105.
181

• HypertensionGuidelines:RevisitingTheJNC7
Recommendations. The Journal Of Lancaster
GeneralHospital•Fall2008•Vol.3–No.3.
• ESCGuidelinesOnTheManagementOfCardiov
ascularDiseasesDuringPregnancy.EuropeanH
eartJournal(2011)32,3147–3197.
• PeripheralSignsOfEndocarditis.FrankL.Urba
no.HospitalPhysicianMay2000.
182

THANKYOU














183
Tags